Characterization of Membrane Protein Interactions in Plasma Membrane Derived Vesicles with Quantitative Imaging Förster Resonance Energy Transfer

Accounts of Chemical Research

Volumn 48, Issue 8, 2015, Pages 2262-2269

  Sarabipour, Sarvenaz ^a   Del Piccolo, Nuala ^a   Hristova, Kalina ^a  

^a Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ACANTHOSIS NIGRICANS; CELL MEMBRANE; CHEMISTRY; CRANIOFACIAL DYSOSTOSIS; DEFICIENCY; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETICS; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; THANATOPHORIC DYSPLASIA; TRANSPORT VESICLE;

ACANTHOSIS NIGRICANS; CELL MEMBRANE; CRANIOFACIAL DYSOSTOSIS; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; THANATOPHORIC DYSPLASIA; TRANSPORT VESICLES;

EID: 84939503746     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/acs.accounts.5b00238     Document Type: Article

References (78)

1. MacKenzie, K. R. Folding and Stability of Alpha-Helical Integral Membrane Proteins Chem. Rev. 2006, 106, 1931-1977 10.1021/cr0404388
2. Hong, H.; Joh, N. H.; Bowie, J. U.; Tamm, L. K. Methods for Measuring the Thermodynamic Stability of Membrane Proteins Methods in Enzymology: Biothermodynamics,Vol 455, Part A 2009, 455, 213-236 10.1016/S0076-6879(08)04208-0
3. Li, E.; Wimley, W. C.; Hristova, K. Transmembrane Helix Dimerization: Beyond the Search for Sequence Motifs Biochim. Biophys. Acta, Biomembr. 2012, 1818, 183-193 10.1016/j.bbamem.2011.08.031
4. Chen, L.; Novicky, L.; Merzlyakov, M.; Hristov, T.; Hristova, K. Measuring the Energetics of Membrane Protein Dimerization in Mammalian Membranes J. Am. Chem. Soc. 2010, 132, 3628-3635 10.1021/ja910692u
5. Chen, L.; Placone, J.; Novicky, L.; Hristova, K. The Extracellular Domain of Fibroblast Growth Factor Receptor 3 Inhibits Ligand-Independent Dimerization Sci. Signaling 2010, 3, ra86 10.1126/scisignal.2001195
6. Placone, J.; Hristova, K. Direct Assessment of the Effect of the Gly380Arg Achondroplasia Mutation on FGFR3 Dimerization Using Quantitative Imaging FRET PLoS One 2012, 7, e46678 10.1371/journal.pone.0046678
7. Placone, J.; He, L.; Del Piccolo, N.; Hristova, K. Strong Dimerization of Wild-Type ErbB2/Neu Transmembrane Domain and the Oncogenic Val664Glu Mutant in Mammalian Plasma Membranes Biochim. Biophys. Acta, Biomembr. 2014, 1838, 2326-2330 10.1016/j.bbamem.2014.03.001
8. Sarabipour, S.; Hristova, K. Glycophorin A Transmembrane Domain Dimerization in Plasma Membrane Vesicles Derived From CHO, HEK 293T, and A431 Cells Biochim. Biophys. Acta, Biomembr. 2013, 1828, 1829-1833 10.1016/j.bbamem.2013.03.022
9. Eswarakumar, V. P.; Lax, I.; Schlessinger, J. Cellular Signaling by Fibroblast Growth Factor Receptors Cytokine Growth Factor Rev. 2005, 16, 139-149 10.1016/j.cytogfr.2005.01.001
10. Schlessinger, J. Common and Distinct Elements in Cellular Signaling Via EGF and FGF Receptors Science 2004, 306, 1506-1507 10.1126/science.1105396
11. Zhang, X. W.; Gureasko, J.; Shen, K.; Cole, P. A.; Kuriyan, J. An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor Cell 2006, 125, 1137-1149 10.1016/j.cell.2006.05.013
12. Robertson, S. C.; Tynan, J. A.; Donoghue, D. J. RTK Mutations and Human Syndromes-When Good Receptors Turn Bad Trends Genet. 2000, 16, 265-271 10.1016/S0168-9525(00)02021-7
13. Galvin, B. D.; Hart, K. C.; Meyer, A. N.; Webster, M. K.; Donoghue, D. J. Constitutive Receptor Activation by Crouzon Syndrome Mutations in Fibroblast Growth Factor Receptor (FGFR) 2 and FGFR2/Neu Chimeras Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 7894-7899 10.1073/pnas.93.15.7894
14. He, L.; Hristova, K. Physical-Chemical Principles Underlying RTK Activation, and Their Implications for Human Disease Biochim. Biophys. Acta, Biomembr. 2012, 1818, 995-1005 10.1016/j.bbamem.2011.07.044
15. Adler, J.; Shevchuk, A. I.; Novak, P.; Korchev, Y. E.; Parmryd, I. Plasma Membrane Topography and Interpretation of Single-Particle Tracks Nat. Methods 2010, 7, 170-171 10.1038/nmeth0310-170
16. Parmryd, I.; Onfelt, B. Consequences of Membrane Topography FEBS J. 2013, 280, 2775-2784 10.1111/febs.12209
17. Sinha, B.; Koster, D.; Ruez, R.; Gonnord, P.; Bastiani, M.; Abankwa, D.; Stan, R. V.; Butler-Browne, G.; Vedie, B.; Johannes, L.; Morone, N.; Parton, R. G.; Raposo, G.; Sens, P.; Lamaze, C.; Nassoy, P. Cells Respond to Mechanical Stress by Rapid Disassembly of Caveolae Cell 2011, 144, 402-413 10.1016/j.cell.2010.12.031
18. Sarabipour, S.; Chan, R. B.; Zhou, B.; Di Paolo, G.; Hristova, K. Analytical Characterization of Plasma Membrane-Derived Vesicles Produced Via Osmotic and Chemical Vesiculation Biochim. Biophys. Acta, Biomembr. 2015, 1848, 1591-1598 10.1016/j.bbamem.2015.04.002
19. Holowka, D.; Baird, B. Structural Studies on the Membrane-Bound Immunoglobulin E-Receptor Complex 0.1. Characterization of Large Plasma-Membrane Vesicles From Rat Basophilic Leukemia-Cells and Insertion of Amphipathic Fluorescent-Probes Biochemistry 1983, 22, 3466-3474 10.1021/bi00283a025
20. Harmer, N. J. Insights into the Role of Heparan Sulphate in Fibroblast Growth Factor Signalling Biochem. Soc. Trans. 2006, 34, 442-445 10.1042/BST0340442
21. Ibrahimi, O. A.; Zhang, F. M.; Hrstka, S. C. L.; Mohammadi, M.; Linhardt, R. J. Kinetic Model for FGF, FGFR, and Proteoglycan Signal Transduction Complex Assembly Biochemistry 2004, 43, 4724-4730 10.1021/bi0352320
22. Scott, R. E. Plasma Membrane Vesiculation: A New Technique for Isolation of Plasma Membrane Science 1976, 194, 743-745 10.1126/science.982044
23. Del Piccolo, N.; Placone, J.; He, L.; Agudelo, S. C.; Hristova, K. Production of Plasma Membrane Vesicles With Chloride Salts and Their Utility As a Cell Membrane Mimetic for Biophysical Characterization of Membrane Protein Interactions Anal. Chem. 2012, 84, 8650-8655 10.1021/ac301776j
24. Sarabipour, S.; Hristova, K. FGFR3 Transmembrane Domain Interactions Persist in the Presence of Its Extracellular Domain Biophys. J. 2013, 105, 165-171 10.1016/j.bpj.2013.05.053
25. Sarabipour, S.; Hristova, K. FGFR3 Unliganded Dimer Stabilization by the Juxtamembrane Domain J. Mol. Biol. 2015, 427, 1705-1714 10.1016/j.jmb.2015.02.013
26. Evers, T. H.; van Dongen, E. M. W. M.; Faesen, A. C.; Meijer, E. W.; Merkx, M. Quantitative Understanding of the Energy Transfer Between Fluorescent Proteins Connected Via Flexible Peptide Linkers Biochemistry 2006, 45, 13183-13192 10.1021/bi061288t
27. Del Piccolo, N.; Placone, J.; Hristova, K. Effect of Thanatophoric Dysplasia Type I Mutations on FGFR3 Dimerization Biophys. J. 2015, 108, 272-278 10.1016/j.bpj.2014.11.3460
28. King, C.; Sarabipour, S.; Byrne, P.; Leahy, D. J.; Hristova, K. The FRET Signatures of Non-Interacting Proteins in Membranes: Simulations and Experiments Biophys. J. 2014, 106, 1309-1317 10.1016/j.bpj.2014.01.039
29. Lemmon, M. A.; Schlessinger, J. Cell Signaling by Receptor Tyrosine Kinases Cell 2010, 141, 1117-1134 10.1016/j.cell.2010.06.011
30. Lin, C. C.; Melo, F. A.; Ghosh, R.; Suen, K. M.; Stagg, L. J.; Kirkpatrick, J.; Arold, S. T.; Ahmed, Z.; Ladbury, J. E. Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2 Cell 2012, 149, 1514-1524 10.1016/j.cell.2012.04.033
31. Low-Nam, S. T.; Lidke, K. A.; Cutler, P. J.; Roovers, R. C.; van Bergen en Henegouwen, P. M.; Wilson, B. S.; Lidke, D. S. ErbB1 Dimerization Is Promoted by Domain Co-Confinement and Stabilized by Ligand Binding Nat. Struct. Mol. Biol. 2011, 18, 1244-1249 10.1038/nsmb.2135
32. Chung, I.; Akita, R.; Vandlen, R.; Toomre, D.; Schlessinger, J.; Mellman, I. Spatial Control of EGF Receptor Activation by Reversible Dimerization on Living Cells Nature 2010, 464, 783-U163 10.1038/nature08827
33. Vajo, Z.; Francomano, C. A.; Wilkin, D. J. The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome With Acanthosis Nigricans Endocr. Rev. 2000, 21, 23-39 10.1210/edrv.21.1.0387
34. L'Hote, C. G. M.; Knowles, M. A. Cell Responses to FGFR3 Signaling: Growth, Differentiation and Apoptosis Exp. Cell Res. 2005, 304, 417-431 10.1016/j.yexcr.2004.11.012
35. Horton, W. A.; Hall, J. G.; Hecht, J. T. Achondroplasia Lancet 2007, 370, 162-172 10.1016/S0140-6736(07)61090-3
36. Shiang, R.; Thompson, L. M.; Zhu, Y.-Z.; Church, D. M.; Fielder, T. J.; Bocian, M.; Winokur, S. T.; Wasmuth, J. J. Mutations in the Transmembrane Domain of FGFR3 Cause the Most Common Genetic Form of Dwarfism, Achondroplasia Cell 1994, 78, 335-342 10.1016/0092-8674(94)90302-6
37. Tavormina, P. L.; Shiang, R.; Thompson, L. M.; Zhu, Y. Z.; Wilkin, D. J.; Lachman, R. S.; Wilcox, W. R.; Rimoin, D. L.; Cohn, D. H.; Wasmuth, J. J. Thanatophoric Dysplasia (Type-I and Type-Ii) Caused by Distinct Mutations in Fibroblast Growth-Factor Receptor-3 Nat. Genet. 1995, 9, 321-328 10.1038/ng0395-321
38. van Rhijn, B. W. G.; van Tilborg, A. A. G.; Lurkin, I.; Bonaventure, J.; De Vries, A.; Thiery, J. P.; van der Kwast, T. H.; Zwarthoff, E. C.; Radvanyi, F. Novel Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations in Bladder Cancer Previously Identified in Non-Lethal Skeletal Disorders Eur. J. Hum. Genet. 2002, 10, 819-824 10.1038/sj.ejhg.5200883
39. van Rhijn, B. W. G.; Montironi, R.; Zwarthoff, E. C.; Jobsis, A. C.; van der Kwast, T. H. Frequent FGFR3 Mutations in Urothelial Papilloma J. Pathol. 2002, 198, 245-251 10.1002/path.1202
40. Fantl, W. J.; Johnson, D. E.; Williams, L. T. Signaling by Receptor Tyrosine Kinases Annu. Rev. Biochem. 1993, 62, 453-481 10.1146/annurev.bi.62.070193.002321
41. Kashles, O.; Szapary, D.; Bellot, F.; Ullrich, A.; Schlessinger, J.; Schmidt, A. Ligand-Induced Stimulation of Epidermal Growth-Factor Receptor Mutants With Altered Transmembrane Regions Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 9567-9571 10.1073/pnas.85.24.9567
42. Carpenter, C. D.; Ingraham, H. A.; Cochet, C.; Walton, G. M.; Lazar, C. S.; Sowadski, J. M.; Rosenfeld, M. G.; Gill, G. N. Structural-Analysis of the Transmembrane Domain of the Epidermal Growth-Factor Receptor J. Biol. Chem. 1991, 266, 5750-5755
43. Weiner, D. B.; Liu, J.; Greene, M. I. A Point Mutation in the Neu Oncogene Mimics Ligand Induction of Receptor Aggregation Nature 1989, 339, 230-231 10.1038/339230a0
44. Webster, M. K.; Donoghue, D. J. Constitutive Activation of Fibroblast Growth Factor Receptor 3 by the Transmembrane Domain Point Mutation Found in Achondroplasia EMBO J. 1996, 15, 520-527
45. Petti, L. M.; Irusta, P. M.; DiMaio, D. Oncogenic Activation of the PDGF Beta Receptor by the Transmembrane Domain of P185(Neu) Oncogene 1998, 16, 843-851 10.1038/sj.onc.1201590
46. Cheatham, B.; Shoelson, S. E.; Yamada, K.; Goncalves, E.; Kahn, C. R. Substitution of the Erbb-2 Oncoprotein Transmembrane Domain Activates the Insulin-Receptor and Modulates the Action of Insulin and Insulin-Receptor Substrate-1 Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 7336-7340 10.1073/pnas.90.15.7336
47. Mendrola, J. M.; Berger, M. B.; King, M. C.; Lemmon, M. A. The Single Transmembrane Domains of ErbB Receptors Self-Associate in Cell Membranes J. Biol. Chem. 2002, 277, 4704-4712 10.1074/jbc.M108681200
48. Artemenko, E. O.; Egorova, N. S.; Arseniev, A. S.; Feofanov, A. V. Transmembrane Domain of EphA1 Receptor Forms Dimers in Membrane-Like Environment Biochim. Biophys. Acta, Biomembr. 2008, 1778, 2361-2367 10.1016/j.bbamem.2008.06.003
49. Chen, L.; Merzlyakov, M.; Cohen, T.; Shai, Y.; Hristova, K. Energetics of ErbB1 Transmembrane Domain Dimerization in Lipid Bilayers Biophys. J. 2009, 96, 4622-4630 10.1016/j.bpj.2009.03.004
50. Li, E.; You, M.; Hristova, K. FGFR3 Dimer Stabilization Due to a Single Amino Acid Pathogenic Mutation J. Mol. Biol. 2006, 356, 600-612 10.1016/j.jmb.2005.11.077
51. Escher, C.; Cymer, F.; Schneider, D. Two GxxxG-Like Motifs Facilitate Promiscuous Interactions of the Human ErbB Transmembrane Domains J. Mol. Biol. 2009, 389, 10-16 10.1016/j.jmb.2009.04.002
52. Finger, C.; Escher, C.; Schneider, D. The Single Transmembrane Domains of Human Receptor Tyrosine Kinases Encode Self-Interactions Sci. Signaling 2009, 2, ra56 10.1126/scisignal.2000547
53. Bell, C. A.; Tynan, J. A.; Hart, K. C.; Meyer, A. N.; Robertson, S. C.; Donoghue, D. J. Rotational Coupling of the Transmembrane and Kinase Domains of the Neu Receptor Tyrosine Kinase Mol. Biol. Cell 2000, 11, 3589-3599 10.1091/mbc.11.10.3589
54. Li, E.; Hristova, K. Role of Receptor Tyrosine Kinase Transmembrane Domains in Cell Signaling and Human Pathologies Biochemistry 2006, 45, 6241-6251 10.1021/bi060609y
55. Lemmon, M. A.; Bu, Z. M.; Ladbury, J. E.; Zhou, M.; Pinchasi, D.; Lax, I.; Engelman, D. M.; Schlessinger, J. Two EGF Molecules Contribute Additively to Stabilization of the EGFR Dimer EMBO J. 1997, 16, 281-294 10.1093/emboj/16.2.281
56. Grasberger, B.; Minton, A. P.; DeLisi, C.; Metzger, H. Interaction Between Proteins Localized in Membranes Proc. Natl. Acad. Sci. U. S. A. 1986, 83, 6258-6262 10.1073/pnas.83.17.6258
57. Hubbard, S. R. Juxtamembrane Autoinhibition in Receptor Tyrosine Kinases Nat. Rev. Mol. Cell Biol. 2004, 5, 464-470 10.1038/nrm1399
58. Red Brewer, M.; Choi, S. H.; Alvarado, D.; Moravcevic, K.; Pozzi, A.; Lemmon, M. A.; Carpenter, G. The Juxtamembrane Region of the EGF Receptor Functions As an Activation Domain Mol. Cell 2009, 34, 641-651 10.1016/j.molcel.2009.04.034
59. Passos-Bueno, M. R.; Wilcox, W. R.; Jabs, E. W.; Sertié, A. L.; Alonso, L. G.; Kitoh, H. Clinical Spectrum of Fibroblast Growth Factor Receptor Mutations Hum. Mutat. 1999, 14, 115-125 10.1002/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.3.CO;2-U
60. van Rhijin, B. W. G.; van Tilborg, A.; Lurkin, I.; Bonaventure, J.; de Vries, A.; Thiery, J. P.; van der Kwast, T. H.; Zwarthoff, E.; Radvanyi, F. Novel Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations in Bladder Cancer Previously Identified in Non-Lethal Skeletal Disorders Eur. J. Hum. Genet. 2002, 10, 819-824 10.1038/sj.ejhg.5200883
61. Meyers, G. A.; Orlow, S. J.; Munro, I. R.; Przylepa, K. A.; Jabs, E. W. Fibroblast-Growth-Factor-Receptor-3 (Fgfr3) Transmembrane Mutation in Crouzon-Syndrome With Acanthosis Nigricans Nat. Genet. 1995, 11, 462-464 10.1038/ng1295-462
62. Chen, F.; Sarabipour, S.; Hristova, K. Multiple Consequences of a Single Amino Acid Pathogenic RTK Mutation: The A391E Mutation in FGFR3 PLoS One 2013, 8, e56521 10.1371/journal.pone.0056521
63. Chen, F.; Degnin, C.; Laederich, M. B.; Horton, A. W.; Hristova, K. The A391E Mutation Enhances FGFR3 Activation in the Absence of Ligand Biochim. Biophys. Acta, Biomembr. 2011, 1808, 2045-2050 10.1016/j.bbamem.2011.04.007
64. Pace, C. N.; Shirley, B. A.; McNutt, M.; Gajiwala, K. Forces Contributing to the Conformational Stability of Proteins FASEB J. 1996, 10, 75-83
65. Fersht, A. R.; Shi, J. P.; Knilljones, J.; Lowe, D. M.; Wilkinson, A. J.; Blow, D. M.; Brick, P.; Carter, P.; Waye, M. M. Y.; Winter, G. Hydrogen-Bonding and Biological Specificity Analyzed by Protein Engineering Nature 1985, 314, 235-238 10.1038/314235a0
66. Williams, D. H.; Searle, M. S.; Mackay, J. P.; Gerhard, U.; Maplestone, R. A. Toward An Estimation of Binding Constants in Aqueous-Solution-Studies of Associations of Vancomycin Group Antibiotics Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 1172-1178 10.1073/pnas.90.4.1172
67. Rousseau, F.; el Ghouzzi, V.; Delezoide, A. L.; Legeai-Mallet, L.; Le Merrer, M.; Munnich, A.; Bonaventure, J. Missense FGFR3Mutations Create Cysteine Residues in Thanatophoric Dwarfism Type I (TD1) Hum. Mol. Genet. 1996, 5, 509-512 10.1093/hmg/5.4.509
68. Adar, R.; Monsonego-Ornan, E.; David, P.; Yayon, A. Differential Activation of Cysteine-Substitution Mutants of Fibroblast Growth Factor Receptor 3 Is Determined by Cysteine Localization J. Bone Miner. Res. 2002, 17, 860-868 10.1359/jbmr.2002.17.5.860
69. d'Avis, P. Y.; Robertson, S. C.; Meyer, A. N.; Bardwell, W. M.; Webster, M. K.; Donoghue, D. J. Constitutive Activation of Fibroblast Growth Factor Receptor 3 by Mutations Responsible for the Lethal Skeletal Dysplasia Thanatophoric Dysplasia Type I Cell Growth & Differentiation 1998, 9, 71-78
70. Krejci, P.; Salazar, L.; Kashiwada, T. A.; Chlebova, K.; Salasova, A.; Thompson, L. M.; Bryja, V.; Kozubik, A.; Wilcox, W. R. Analysis of STAT1 Activation by Six FGFR3Mutants Associated With Skeletal Dysplasia Undermines Dominant Role of STAT1 in FGFR3 Signaling in Cartilage PLoS One 2008, 3, e3961 10.1371/journal.pone.0003961
71. Naski, M. C.; Wang, Q.; Xu, J. S.; Ornitz, D. M. Graded Activation of Fibroblast Growth Factor Receptor 3 by Mutations Causing Achondroplasia and Thanatophoric Dysplasia Nat. Genet. 1996, 13, 233-237 10.1038/ng0696-233
72. Bonaventure, J.; Gibbs, L.; Horne, W. C.; Baron, R. The Localization of FGFR3Mutations Causing Thanatophoric Dysplasia Type I Differentially Affects Phosphorylation, Processing and Ubiquitylation of the Receptor FEBS J. 2007, 274, 3078-3093 10.1111/j.1742-4658.2007.05835.x
73. Harada, D.; Yamanaka, Y.; Ueda, K.; Tanaka, H.; Seino, Y. FGFR3-Related Dwarfism and Cell Signaling J. Bone Miner. Metab. 2009, 27, 9-15 10.1007/s00774-008-0009-7
74. Adar, R.; Monsonego-Ornan, E.; David, P.; Yayon, A. Differential Activation of Cysteine-Substitution Mutants of Fibroblast Growth Factor Receptor 3 Is Determined by Cysteine Localization J. Bone Miner. Res. 2002, 17, 860-868 10.1359/jbmr.2002.17.5.860
75. Greulich, H.; Kaplan, B.; Mertins, P.; Chen, T. H.; Tanaka, K. E.; Yun, C. H.; Zhang, X. H.; Lee, S. H.; Cho, J. H.; Ambrogio, L.; Liao, R.; Imielinski, M.; Banerji, S.; Berger, A. H.; Lawrence, M. S.; Zhang, J. H.; Pho, N. H.; Walker, S. R.; Winckler, W.; Getz, G.; Frank, D.; Hahn, W. C.; Eck, M. J.; Mani, D. R.; Jaffe, J. D.; Carr, S. A.; Wong, K. K.; Meyerson, M. Functional Analysis of Receptor Tyrosine Kinase Mutations in Lung Cancer Identifies Oncogenic Extracellular Domain Mutations of ERBB2 Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 14476-14481 10.1073/pnas.1203201109
76. Phay, J. E.; Shah, M. H. Targeting RET Receptor Tyrosine Kinase Activation in Cancer Clin. Cancer Res. 2010, 16, 5936-5941 10.1158/1078-0432.CCR-09-0786
77. Iyer, G.; Milowsky, M. I. Fibroblast Growth Factor Receptor-3 in Urothelial Tumorigenesis Urologic Oncology-Seminars and Original Investigations 2013, 31, 303-311 10.1016/j.urolonc.2011.12.001
78. Belov, A. A.; Mohammadi, M. Grb2, a Double-Edged Sword of Receptor Tyrosine Kinase Signaling Sci. Signaling 2012, 5, pe49 10.1126/scisignal.2003576